Published Guidance, NICE advice and quality standards

Skip to filters Skip to results

Showing 701 to 750 of 752

Sort by

Type: GuidanceRemove Type: Guidance filter
Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin	TA159	22 October 2008	22 October 2008
Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults	TA157	24 September 2008	24 September 2008
Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza	TA158	24 September 2008	24 September 2008
Routine antenatal anti-D prophylaxis for women who are rhesus D negative	TA156	27 August 2008	27 August 2008
Entecavir for the treatment of chronic hepatitis B	TA153	27 August 2008	27 August 2008
Telbivudine for the treatment of chronic hepatitis B	TA154	27 August 2008	27 August 2008
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus	TA151	23 July 2008	23 July 2008
Bevacizumab for the treatment of non-small-cell lung cancer (terminated appraisal)	TA148	25 June 2008	25 June 2008
Carmustine implants for the treatment of recurrent glioblastoma multiforme (terminated appraisal)	TA149	25 June 2008	25 June 2008
Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck	TA145	25 June 2008	25 June 2008
Adalimumab for the treatment of adults with psoriasis	TA146	25 June 2008	25 June 2008
Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over	TA138	26 March 2008	26 March 2008
Structural neuroimaging in first-episode psychosis	TA136	27 February 2008	27 February 2008
Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma	TA137	27 February 2008	27 February 2008
Infliximab for the treatment of adults with psoriasis	TA134	23 January 2008	23 January 2008
Pemetrexed for the treatment of malignant pleural mesothelioma	TA135	23 January 2008	23 January 2008
Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years	TA131	28 November 2007	28 November 2007
Bortezomib monotherapy for relapsed multiple myeloma	TA129	23 October 2007	23 October 2007
Stapled haemorrhoidopexy for the treatment of haemorrhoids	TA128	26 September 2007	26 September 2007
Pemetrexed for the treatment of non-small-cell lung cancer	TA124	22 August 2007	22 August 2007
Natalizumab for the treatment of adults with highly active relapsing–remitting multiple sclerosis	TA127	22 August 2007	22 August 2007
Varenicline for smoking cessation	TA123	25 July 2007	25 July 2007
Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma	TA121	27 June 2007	27 June 2007
Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia	TA119	28 February 2007	28 February 2007
Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy	TA117	24 January 2007	24 January 2007
Methadone and buprenorphine for the management of opioid dependence	TA114	24 January 2007	24 January 2007
Naltrexone for the management of opioid dependence	TA115	24 January 2007	24 January 2007
Gemcitabine for the treatment of metastatic breast cancer	TA116	24 January 2007	24 January 2007
Laparoscopic surgery for colorectal cancer	TA105	23 August 2006	23 August 2006
Etanercept and efalizumab for the treatment of adults with psoriasis	TA103	26 July 2006	26 July 2006
Docetaxel for the treatment of hormone-refractory metastatic prostate cancer	TA101	28 June 2006	28 June 2006
Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer	TA100	26 April 2006	26 April 2006
Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B	TA96	22 February 2006	22 February 2006
HealOzone for the treatment of tooth decay (occlusal pit and fissure caries and root caries)	TA92	27 July 2005	27 July 2005
Guidance on the use of paclitaxel in the treatment of ovarian cancer	TA55	22 January 2003	1 May 2005
Laparoscopic surgery for inguinal hernia repair	TA83	22 September 2004	22 September 2004
Tacrolimus and pimecrolimus for atopic eczema	TA82	25 August 2004	25 August 2004
Frequency of application of topical corticosteroids for atopic eczema	TA81	25 August 2004	25 August 2004
Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia	TA77	28 April 2004	28 April 2004
Fluid-filled thermal balloon and microwave endometrial ablation techniques for heavy menstrual bleeding	TA78	28 April 2004	28 April 2004
Pre-hospital initiation of fluid replacement therapy in trauma	TA74	28 January 2004	28 January 2004
Guidance on the use of liquid-based cytology for cervical screening	TA69	22 October 2003	22 October 2003
Human growth hormone (somatropin) in adults with growth hormone deficiency	TA64	27 August 2003	27 August 2003
Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer	TA61	27 May 2003	27 May 2003
Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction	TA52	30 October 2002	30 October 2002
Guidance on the use of ultrasound locating devices for placing central venous catheters	TA49	4 October 2002	4 October 2002
Inhaler devices for routine treatment of chronic asthma in older children (aged 5–15 years)	TA38	27 March 2002	27 March 2002
Guidance on the use of trastuzumab for the treatment of advanced breast cancer	TA34	15 March 2002	15 March 2002
Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia	TA29	26 September 2001	26 September 2001
Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone disease	TA20	23 January 2001	23 January 2001

Results per page

10
25
50
All